CN Patent

CN105330595B — 吡啶衍生物及其作为抗分支杆菌的应用

Assigned to CISEN PHARMACEUTICAL Co Ltd · Expires 2019-12-10 · 6y expired

What this patent protects

本发明公开了一系列新颖的吡啶衍生物的制备方法和应用。此类衍生物可用于治疗由分支杆菌引起的相关疾病，尤其是针对由致病性分支杆菌引起的疾病，如结核分枝杆菌，牛分支杆菌，鸟分支杆菌，及海分支杆菌。

USPTO Abstract

本发明公开了一系列新颖的吡啶衍生物的制备方法和应用。此类衍生物可用于治疗由分支杆菌引起的相关疾病，尤其是针对由致病性分支杆菌引起的疾病，如结核分枝杆菌，牛分支杆菌，鸟分支杆菌，及海分支杆菌。

Drugs covered by this patent

bedaquiline-fumarate (BEDAQUILINE FUMARATE)

Patent Metadata

Patent number: CN105330595B
Jurisdiction: CN
Classification: —
Expires: 2019-12-10
Drug substance claim: No
Drug product claim: No
Assignee: CISEN PHARMACEUTICAL Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.